bismuth has been researched along with Fibrosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Himeno, S; Imura, N; Kondo, Y; Naganuma, A; Nishimura, T; Satoh, M | 1 |
1 other study(ies) available for bismuth and Fibrosarcoma
Article | Year |
---|---|
Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum.
Topics: Administration, Oral; Animals; Bismuth; Cisplatin; Citric Acid; Drug Synergism; Fibrosarcoma; Kidney; Kidney Diseases; Male; Metallothionein; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Protective Agents; Tissue Distribution | 2004 |